Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$42.9

Avg closing price
Price range

5 Ray Dalio Ultragenyx Pharmaceutical Trades

Ray Dalio started to build up the position in Ultragenyx Pharmaceutical in Q1 2023. Since then they sold 13.7 Thousand shares. The investor completely sold their stake between Q2 2023 and Q1 2024.

Avg closing price
Price range
Sold -10.6 Thousand shares Q1 2024
Avg closing price $47.17
Price range $43.02 - $53.69
Sold 6.6% shares (-754 shares) Q4 2023
Avg closing price $38.77
Price range $31.73 - $49.19
Sold 4.8% shares (-573 shares) Q3 2023
Avg closing price $39.62
Price range $34.92 - $46.66
Sold 12.5% shares (-1.71 Thousand shares) Q2 2023
Avg closing price $46.38
Price range $37.35 - $52.15
New holding (+13.7 Thousand shares) Q1 2023
Avg closing price $42.91
Price range $36.99 - $48.71

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!